DrugPatentWatch Database Preview
Drugs in Development Information for BGB-3111
» See Plans and Pricing
What is the drug development status for BGB-3111?
BGB-3111 is an investigational drug.
There have been 79 clinical trials for BGB-3111.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 2nd 2017.
The most common disease conditions in clinical trials are Lymphoma, Neoplasms, and Carcinoma. The leading clinical trial sponsors are BeiGene, BeiGene USA, Inc., and M.D. Anderson Cancer Center.
There are five US patents protecting this investigational drug and thirty-eight international patents.
Summary for BGB-3111
| US Patents | 5 |
| International Patents | 38 |
| US Patent Applications | 9 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-11-02) |
| Vendors | 12 |
Recent Clinical Trials for BGB-3111
| Title | Sponsor | Phase |
|---|---|---|
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19) | BeiGene | Phase 2 |
| Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma | Sun Yat-sen University | Phase 2 |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | BeiGene | Phase 1 |
Clinical Trial Summary for BGB-3111
Top disease conditions for BGB-3111
Top clinical trial sponsors for BGB-3111
US Patents for BGB-3111
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BGB-3111 | Start Trial | Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators | BEIGENE, LTD. (Grand Cayman, KY) | Start Trial |
| BGB-3111 | Start Trial | Treatment of pemphigus | PRINCIPIA BIOPHARMA INC. (South San Francisco, CA) | Start Trial |
| BGB-3111 | Start Trial | Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators | BEIGENE SWITZERLAND GMBH (Basel, CH) | Start Trial |
| BGB-3111 | Start Trial | Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators | BeiGene, Ltd. (George Town, KY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BGB-3111
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BGB-3111 | Australia | 2014256633 | 2033-04-25 | Start Trial |
| BGB-3111 | Brazil | 112015025260 | 2033-04-25 | Start Trial |
| BGB-3111 | Canada | 2902686 | 2033-04-25 | Start Trial |
| BGB-3111 | China | 104884458 | 2033-04-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
